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Background: The MetNI transporter drives methionine import against its concentration gradient and regulates intracel-
lular methionine levels.
Results:Methionine is a noncompetitive inhibitor of MetNI ATPase activity, binding the transporter at two allosteric sites.
Conclusion:MetNI regulates intracellular methionine concentrations via allosteric regulation.
Significance:Regulation ofmethionine import at the protein level mayminimize wasteful consumption of ATPwhen adequate
intracellular supplies are available.
The MetNI methionine importer of Escherichia coli, an ATP
binding cassette (ABC) transporter, uses the energy of ATP
binding and hydrolysis to catalyze the high affinity uptake of D-
and L-methionine. Early in vivo studies showed that the uptake
of external methionine is repressed by the level of the internal
methionine pool, a phenomenon termed transinhibition. Our
understanding of the MetNI mechanism has thus far been lim-
ited to a series of crystal structures in an inward-facing confor-
mation. To understand the molecular mechanism of transinhi-
bition, we studied the kinetics of ATP hydrolysis using
detergent-solubilized MetNI. We find that transinhibition is
due to noncompetitive inhibition by L-methionine, much like a
negative feedback loop. Thermodynamic analyses revealed two
allosteric methionine binding sites per transporter. This quan-
titative analysis of transinhibition, the first to our knowledge for
a structurally defined transporter, builds upon the previously
proposed structurally based model for regulation. This mecha-
nism of regulation at the transporter activity level could be
applicable to not onlyABC transporters but other types ofmem-
brane transporters as well.
Early in vivo studies by Kadner and colleagues (1, 2) estab-
lished that Escherichia coli utilizes a high affinity transport sys-
tem that mediates the energy-dependent uptake of D- and
L-methionine into cells. These elegant studies further demon-
strated that uptake of external methionine is repressed by the
level of the internal methionine pool, a phenomenon called
transinhibition (3). As a result, the cell is able to regulate uptake
of extracellular methionine to maintain an appropriate intra-
cellular concentration, thereby minimizing the wasteful con-
sumption of energy.
The high affinity import system of E. coli was subsequently
identified as MetNI, a member of the ATP binding cassette
(ABC)2 family of transporters (4–6). The MetNI importer, as
with all ABC transporters, consists of two nucleotide binding
domains (NBDs) and two transmembrane domains (TMDs)
(7). ATP binding and hydrolysis occur at the interface between
the highly conservedNBDs, where ATP is sandwiched between
the Walker A motif of one monomer and the ABC motif
(LSGGQ) on the other (8–10). Based on the TMD fold
observed in the crystal structure (see Fig. 1A), MetNI was cat-
egorized as a Type I importer, with other structurally charac-
terized members including the ModBC molybdate transporter
and theMalFGK2maltose transporter (11–14). For this class of
importers, the alternating access transport mechanism pro-
poses that ATP binding at the NBD interface induces the clo-
sure, or “dimerization” of the two domains, thereby promoting
an outward-facing conformation of the TMDs (15). The inter-
nal cavity of the transporter is thus open to receive substrate
from the cognate periplasmic binding protein. SubsequentATP
hydrolysis releases NBD dimerization and converts the TMDs
to an inward-facing conformation where substrate can be
released to the cytoplasm (see Fig. 1B).
In addition to this common domain architecture, the MetNI
NBDs are fused to two carboxyl-terminal domains, termed C2,
which are believed to be crucial for transinhibition (11, 12). The
MetNI C2 domains are distinct from those found on the
ModBC andMalFGK2 transporters, although all are implicated
in regulatory roles of transport (13, 16). The high-resolution
crystal structure of MetNI shows the NBDs widely separated
due to dimerization of their C2 domains (see Fig. 1A). Sel-
enomethionine has been shown to bind the C2 domains and
inhibit ATPase activity. Based on these findings, it has been
proposed that ligand-dependent association of the C2 domains
prevents dimerization of theNBDs. Because the twoATP bind-* Thisworkwas supported, inwholeor inpart, byNational Institutes ofHealth
Grant R01 GM45162 (to D. C. R.).
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ing pockets are created at this dimerization interface, physical
separation of the NBDs will prevent ATP binding and hydroly-
sis, thereby inhibiting transport (see Fig. 1B) (11).
MetNI provides a rare opportunity to develop detailed
kinetic and thermodynamic analyses to study themechanismof
a structurally characterized ABC transporter. As a starting
point, we examine the kinetics of ATP hydrolysis to elucidate
the mechanism of MetNI transinhibition. To focus on the
inhibitory effects of methionine, we employed a basic experi-
mental system consisting of detergent-solubilizedMetNI in the
absence ofMetQ, the substrate-containing cognate periplasmic
binding protein. Although MetQ will clearly influence the
structure and activity of MetNI (see Ref. 17 for an informative
discussion of the maltose transport system), it will also compli-
cate an analysis of the role of methionine because the stimulat-
ing effect of MetQ on the ATPase activity is opposite of the
allosteric effect of methionine. As a consequence, we have not
includedMetQ in these studies. Additionally, the basal ATPase
activity of detergent-solubilized ABC transporters typically
increases and the coupling efficiency decreases, relative to the
behavior in a phospholipid bilayer, as again exemplified by the
maltose transporter (see Ref. 18). Although ATPase activity
uncoupled to transport is not the physiological reaction of ABC
transporters, comparisons of ABC subunits in isolation and in
transporters are suggestive of a common mechanism for ATP
hydrolysis (19). Consequently, meaningful kinetic interpreta-
tions can be derived from the effects of methionine on the rel-
ative ATPase activity of MetNI in our simplified system. We
find that transinhibition is due to noncompetitive inhibition by
L-methionine and that there are two allosteric methionine
binding sites per transporter. These findings are consistent
with the structurally basedmodel for transinhibition and could
be extended to understanding the regulation of the broader
ABC family.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—The wild-type His-
tagged MetNI expression plasmid (11) was transformed into
BL21-Gold (DE3) cells (Novagen). Cell growthwas carried out
at 37 °C in Terrific Broth containing 1% glucose and 100 g/ml
ampicillin. Protein expression was induced by the addition of
isopropyl -D-1-thiogalactopyranoside to 1 mM for 1 h. Cells
were harvested by centrifugation and stored at80 °C.
Frozen cell pellets were homogenized in purification buffer
(50 mM TAPS, pH 8.5, 250 mM NaCl, 0.05% n-dodecyl-
-D-maltopyranoside (DDM, Anatrace)) supplemented with
DNase, lysozyme, and protease inhibitor tablets (Roche Diag-
nostics GmbH). To extract MetNI protein, DDMwas added to
1.0% final concentration. Cells were stirred at 4 °C for 20 min
and then passed through a Microfluidizer three times. The cell
lysate was stirred for 20min and then spun for 20min at 16,000
rpm in a JLA 17 rotor. The supernatant was recovered, and
imidazole was added to 25 mM final concentration. The super-
natant was then flowed over three tandem 5-ml HisTrap FF
columns (GE Healthcare) and washed with 2 column volumes
of purification buffer containing 25 mM imidazole and 5 col-
umn volumes of purification buffer containing 75 mM imidaz-
ole. MetNI protein was eluted with purification buffer contain-
ing 350 mM imidazole. Eluate was then buffer-exchanged into
purification buffer without imidazole using a HiPrep 26/10
desalting column (GE Healthcare). The protein was then sized
over a Superdex 200 column (GEHealthcare) and concentrated
to60 M in an Amicon Ultra 100-kDa molecular mass cutoff
centrifugal filter (Millipore) prewashed in purification buffer.
Purified protein was flash-frozen in LN2 and stored at80 °C.
ATPase Assays—The amount of inorganic phosphate gener-
ated in solution was measured in real time using the Enzchek
phosphate assay kit (Molecular Probes). Each 100-l reaction
contained 60 mM Tris, pH 7.5, 5 mM TAPS, pH 8.5, 0.055%
DDM, 55mMNaCl, 200M 2-amino-6-mercapto-7-methylpu-
rine riboside, 0.1 units of purine nucleoside phosphorylase,
equimolar amounts of MgCl2 and ATP and/or ADP, and L-me-
thionine as indicated. Data were collected on an Infinite M200
microplate reader (TecanGroup) at 33 °C. Reactionswere incu-
bated for 2 min and then initiated by automatic injection of
MetNI (supplemental Fig. S1). For measurement of KI(ADP), 3
M MetNI final concentration was injected into reactions con-
taining 100 MMgATP. For all other measurements, reactions
contained 410 nM MetNI. Initial rates were obtained by calcu-
lating the linear portion of the change in absorbance at 360 nm
as a function of time using Magellan software. Error bars rep-
resent S.E. from at least three independent experiments.
All data were fit using KaleidaGraph (Synergy Software). For
determination of KI values, the initial rate was plotted against
inhibitor concentration and fit to the following equation
v 
Vmax
app
1
InI
KI
nI
(Eq. 1)
where [I] is the inhibitor concentration, KI is the inhibition
constant, and nI is the Hill coefficient for the inhibitor.
For determination of Km(ATP), Vmax, and the Hill coefficient
nATP, the initial ratewas plotted againstATPconcentration and
fit to the following equation
v 
Vmax ATP
nATP
Km
nATP ATPnATP
(Eq. 2)
Isothermal Titration Calorimetry—MetNI was further con-
centrated to 350–450 M in an Amicon Ultra 100-kDa molec-
ularmass cutoff centrifugal filter (Millipore) prewashed in puri-
fication buffer. Samples were then dialyzed overnight in
purification buffer in 100-kDa molecular mass cutoff Slide-a-
Lyzer MINI dialysis devices (Thermo Scientific). The next day,
samples were recovered and cleared at 95,000 rpm for 10min in
a TLA100 rotor. L-Methionine (BioUltra, Sigma) was reconsti-
tuted in the purification buffer used for dialysis. Binding data
were collected on a MicroCal iTC-200 calorimeter at 25 °C.
300–450 M MetNI was titrated with 8–10 mM L-methionine.
For each experiment, an initial injection of 0.4 l was followed
by 19 injections of 2 l each. The sample cell was allowed to
equilibrate for 180 s between titrations. Data were processed
using Origin v7.0 (OriginLab). Error bars represent S.E. from at
least three independent experiments.
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RESULTS
To establish the kinetic mechanism of transinhibition, we
measured the ATPase activity of detergent-solubilized, wild-type
MetNIusingacontinuousspectrophotometriccoupledenzymatic
assay (see “Experimental Procedures”). Todefine the basic param-
eters of the assay,MetNIwas automatically injected into reactions
containing varying concentrations of MgATP. The initial rates
were plotted and fit to a sigmoidal curve with Km 330 20M
and aHill coefficient of 1.7 0.1, indicating positive cooperativity
between the twoATPbinding pockets (Fig. 1C and supplemental
Fig. S1). Cooperative binding of ATP is a common feature of sev-
eral ABC transporters, including the vitamin B12, maltose, and
histidine transporters (20–23).
We then verified the competitive nature of nucleotide inhi-
bition of MetNI ATPase activity. Because canonical nucleotide
analogs for ATP, including AMPPNP, AMPPCP, and ATPS,
did not completely inhibit ATPase activity in the concentration
range tested (data not shown), we measured ATPase inhibition
using ADP. Under subsaturating ATP concentrations, ADP
inhibited MetNI ATPase activity with a KI(ADP) of 41  2 M
and a Hill coefficient of 1.3 0.1, indicating low cooperativity
for the binding of ADP (Fig. 2A and Table 1). Next, the ATP
concentration was varied under constant ADP concentrations
both above and below the measured KI(ADP). In the presence of
ADP, the apparent Vmax remained unchanged, whereas the
apparent Km increased with increasing inhibitor concentration
(Fig. 2B and Table 2). As expected, these experiments con-
firmed that ADP is indeed a competitive inhibitor.
We next tested L-methionine inhibition of MetNI ATPase
activity. Inhibition experiments under saturatingATPconcentra-
tions were fit to a KI(L-Met) of 41 1 M and a Hill coefficient of
1.4 0.1, indicating that there ismore than onemethionine bind-
ing site perMetNI transporter and low cooperativity between the
sites (Fig. 3A and Table 1). Furthermore, with increasing L-methi-
onine concentrations, the apparent Vmax significantly decreased,
whereas the apparentKm remained constant (Fig. 3B andTable 2).
These data suggest that L-methionine is a noncompetitive inhibi-
tor of MetNI ATPase activity. To further support this model, we
conducted isothermal titration calorimetry experiments using
L-methionine as the ligand (Fig. 3C). L-Methionine bound to
MetNI at 2.2 0.1 sites, with a KD(L-Met) of 33 4 M. Although
theerror estimatesprovidedby the software analysis are artificially
low (see reduced 	-squared values for fixed values of stoichiome-
try, Fig. 3C, inset), the measured value for the KD(L-Met) is in the
same order of magnitude of the KI(L-Met) for the ATPase reaction
(41 1M).
DISCUSSION
Wehave demonstrated that L-methionine can bind toMetNI
at allosteric sites, resulting in the noncompetitive inhibition of
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FIGURE 1. Binding of ATP to MetNI is cooperative. A, representation of MetNI structure and domains within the cell membrane (11). B, alternating access
model for transport with the addition of the transinhibitionmodel. C, ATPase activity ofMetNI in the absence of inhibitors. Inset, observed rate constant at low
concentrations of MgATP. Reaction conditions consisted of 60 mM Tris, pH 7.5, 5 mM TAPS, pH 8.5, 0.055% DDM, 55 mM NaCl, 200 M 2-amino-6-mercapto-7-
methylpurine riboside, 0.1 units of purine nucleoside phosphorylase per 100 l, and equimolar amounts of MgCl2 and ATP at 33 °C. Equations for fitting are
described under “Experimental Procedures.” Error bars represent S.E. from at least three independent experiments.
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ATP hydrolysis. This direct modulation of MetNI activity is
consistent with the model based on the crystallographically
observed ATPase-inactive state of MetNI. Our data suggest
that the transinhibition phenomenon observed by Kadner (3)
can be attributed to the regulation of methionine import at the
protein activity level. The de novo biosynthesis ofmethionine in
E. coli is costly, requiring 7 ATPs and 8 NADPHs per molecule
of methionine (24). If extracellular methionine is available,
uptake of the exogenous methionine at an estimated cost of
2 ATPs per methionine molecule would be energetically
preferable to de novo biosynthesis. The homeostatic intra-
cellular concentration of methionine is estimated to be 150
M (25), maintained by the balance between the rate of
appearance of methionine via the MetNI import system
and/or the methionine biosynthesis pathway and the rate of
disappearance via protein synthesis and other processes.
Given the KI for methionine inhibition measured in this
study (40M), uptake should occur under conditions when
the intracellular levels of methionine are well below 150 M,
with the rate of transport decreasing as the interior concen-
tration increases.
Several aspects of our study are worth detailing. We have
kinetically analyzed the influence ofmethionine on the ATPase
activity of detergent-solubilized MetNI in the absence of the
MetQ binding protein and in the absence of phospholipid. For
the kinetic analysis, we have used the simplest models for non-
competitive and competitive inhibition to treat the effects of
methionine and ADP, respectively, on ATPase activity. These
models do not include binding interactions between ligands.
We have explored more complex kinetic models (see the
supplemental text), which suggest that little interaction occurs
in the binding of these ligands. Given the correlation of param-
eters intrinsic to these binding models (26), it is not possible to
confidently assess the magnitudes of these effects. The MetQ
binding protein was not utilized in these studies to avoid the
opposing effects ofmethionine onATPase activity due to trans-
port (requiring methionine-bound MetQ) and to transinhibi-
tion (requiring methionine acting as an allosteric ligand). We
have focused on detergent-solubilized MetNI to directly char-
acterize the influence of methionine on the ATPase activity of
the form ofMetNI that has been crystallographically character-
ized. Although the physiological function of ABC transporters
requires membranes, detergent-solubilized transporters can
capture important functional properties. The most extensive
mechanistic studies of ABC importers have been conducted for
the MalFGK2 transporter; although the detailed properties dif-
fer, the cooperativity of ATP hydrolysis can be observed for
both detergent-solubilized and proteoliposome-reconstituted
ABC transporters (22). Furthermore, complexes between the
maltose transporter and binding protein can be trapped using
ATP 	 vanadate with either membrane-bound or detergent-
solubilized transporter (27). Unquestionably, the structural
studies on detergent-solubilized maltose transporter from the
Chen group (14, 17) and on detergent-solubilized vitamin B12
transporter from the Locher group (20, 28) have provided an
invaluable framework for the interpretation of mechanistic
studies of transport in proteoliposomes.
ABC transporters have adopted a wide range of mechanisms
to regulate their activity. The molybdate/tungstate transporter
ModBC shares a similar architecturewithMetNI and also dem-
onstrates transinhibitory behavior at higher concentrations of
substrate (13). Themaltose transporter, in contrast, is regulated
by an additional protein that responds to nutrient availability.
Unphosphorylated EIIAGlc binds MalFGK2 when preferred
sources of carbon, such as glucose, are available (29). Two
EIIAGlc molecules bind the NBDs and promote the inward-
facing conformation reminiscent of the MetNI inhibited
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FIGURE 2.ADP is a competitive inhibitor ofMetNI ATPase activity.A, inhibition ofMetNI ATPase activity as a function of ADP concentration. Inset, observed
rate constant at low concentrations of MgATP. B, ATPase activity as a function of ATP concentration in the presence of different concentrations of ADP.
Reaction conditions were identical with those in Fig. 1. Error bars represent S.E. from at least three independent experiments.
TABLE 1
Inhibition constants
Inhibitor KI Hill coefficient
M
ADP 41 2 1.3 0.1
L-Met 41 1 1.4 0.1
TABLE 2
Kinetic parameters from the ATPase reaction
Inhibitor Vmaxapp Kmapp
min1 M
None 17 1 330 20
30 M ADP 19 1 660 40
75 M ADP 21 1 1170 80
120 M ADP 20 1 1490 140
25 M L-Met 13 1 309 19
50 M L-Met 7 1 325 15
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state (16). Interestingly, it has been demonstrated that the
binding of EIIAGlc does not affect the binding of ATP but
rather inhibits ATP hydrolysis by MalK (30). Quantitative
modeling of our MetNI data suggests that methionine may
similarly inhibit ATP hydrolysis but not ATP binding (see
the supplemental text).
Although the above examples highlight inhibition as the
result of a stabilized inward-facing conformation, ABC trans-
porters are also regulated at the level of transcription, glycosyl-
ation, and direct phosphorylation. For example, the osmoregu-
latory transporterOpuA is regulated by the transcription factor
OpuR in response to osmotic stress (31). CFTR (cystic fibrosis
transmembrane conductance regulator), an ABC-type chloride
channel whose malfunction is linked to cystic fibrosis, is gated
by PKA-mediated phosphorylation of its cytoplasmic regula-
tory domain (32–35). Lastly, it is hypothesized that glycosylation
mayhelp stabilize the rodphotoreceptorABCtransporter (ABCR)
against degradation while in the endoplasmic reticulum (36).
TheregulationofABCtransporters,whether throughaccessory
proteins, regulatory domains, or posttranslational modifications,
is critical to balance the transport of metabolites for optimal
growth. TheMetNI transporter, through transinhibition, is effec-
tively able to shut off import when adequate intracellular methio-
nine is available for crucial cellular processes. A possible mecha-
nism for this phenomenon envisioned nearly 40 years ago by
Kadner (3) on the basis of transport studies in E. coli cells (“ . . .
internalmethionine binds to the carrier on the internal face of the
membrane. Thismethionine-carrier complexmight be unable, or
at least less able, to undergo the energy-dependent change neces-
sary for active transport . . . ”) was prescient, as the present studies
have established using purified components. Significantly, the
underlying mechanism (ligand binding to regulatory domains
inhibits NBD dimerization, thereby preventing ATP hydrolysis
and effectively “turning off the engine”) exemplifies a broadly rel-
evantmechanismfor regulating theactivityofABCtransporters at
the protein level.
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FIGURE 3. L-Methionine is a noncompetitive inhibitor. A, inhibition of MetNI ATPase activity as a function of L-Met concentration. Inset, observed rate
constant at low concentrations of MgATP. B, ATPase activity as a function of ATP concentration in the presence of different concentrations of L-Met.
Reaction conditions for ATPase assays were identical with those in Fig. 1. Error bars represent S.E. from at least three independent experiments. C, top,
representative ITC thermogram profile for association of L-Met ligand with MetNI reactant. Bottom, binding curve from plot of heats from each injection
as a function of the ratio of L-Met to MetNI, c  14. Buffer conditions for ITC experiments consisted of 50 mM TAPS, pH 8.5, 250 mM NaCl, 0.05%
n-dodecyl--D-maltopyranoside at 25 °C. Binding of L-methionine was exothermic with 
H2140 40 cal mol1. Inset: reduced 	-squared value for
ITC data fit as function of stoichiometry, N.
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Figure S1. Representative raw data for ATPase assays.  The amount of inorganic phosphate 
generated in solution was measured in real-time using the Enzchek Phosphate Assay Kit 
(Molecular Probes).  Each 100 μl reaction contained 60 mM Tris, pH 7.5, 5 mM TAPS, pH 8.5, 
0.055% DDM, 55 mM NaCl, 200 μM 2-amino-6-mercapto-7-methylpurine riboside, 0.1 units of 
purine nucleoside phosphorylase, equimolar amounts of MgCl2 and ATP. Data were collected 
on an Innite M200 microplate reader (Tecan Group) at 33°C.  Reactions were incubated for 2 
minutes and then initiated by automatic injection of MetNI to a nal concentration of 410 nM. 
Initial rates were obtained by calculating the linear portion of the change (200-400 sec) in 
absorbance at 360 nm as a function of time. 
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B
A
Figure S2. Graphical representations of positive cooperativity for MgATP.  Data from 
Figure 1C replotted as (A) Eadie-Hofstee plot and (B) Lineweaver-Burk plot.
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Figure S3.  Theoretical models for competitive and noncompetitive inhibition.  
All values represent intrinsic dissociation constants.  A, Thermodynamic scheme for 
competitive inhibition by ADP. MetNI is represented by “E”; ATP by “T”, and ADP by “D”.  
B, Fit of ADP data using model depicted in (A). Blue, no ADP; red, 30 μM ADP; green, 
75 μM ADP; yellow, 120 μM ADP.  C, Thermodynamic scheme for noncompetitive 
inhibition by L-methionine. MetNI is represented by “E”; ATP by “T”, and L-met by “M”. 
D, Fit of L-met data using model depicted in (C). Blue, no L-met; red, 25 μM L-met; 
green, 50 μM L-met.  
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Modeling of MetNI inhibition 
 
Using the kinetic data, we generated several models to quantitatively test different 
thermodynamic schemes for inhibition. Nonlinear regression analysis was performed 
using Mathematica’s NonlinearModelFit function.  Equations for fitting were derived as 
per Segel (see below) (1). 
 
All models require the binding of two ATP molecules per transporter for hydrolysis, as 
supported by the cooperativity observed in Fig 1B. Additionally, crystallographic studies 
of ABC subunits suggest that two bound ATP molecules are needed to stabilize the 
interface between the TMDs (2,3). While ATP hydrolysis may occur with only 1 bound 
ATP, as suggested by the Hill coefficient of 1.7, we chose to not include this species in 
our modeling studies to minimize the number of refined parameters. For ADP inhibition, 
the data best fit a model where one MetNI transporter (“E”) can bind one molecule of 
ATP (“T”) and one molecule of ADP (“D”) simultaneously (Fig S3, A-B and Table S1).  
The presence of the mixed state, DET and TED, is not unexpected; it is conceivable that 
MetNI could hydrolyze only one ATP at a time, although this condition was not required 
to fit the kinetic model. The doubly bound DED state has been observed 
crystallographically in an inward facing conformation (4). More detailed comparisons of 
binding affinities were difficult to infer due to the large standard errors, a consequence of 
the highly correlative nature of the model parameters (5).   
 
The model for L-methionine inhibition is more complicated, as there are two binding 
sites for ATP and two allosteric binding sites for L-methionine (“M”) per one transporter 
(Fig S3, C-D and Table S1).  The data best fit a model in which only one species is able 
to hydrolyze ATP.  The single catalytically active species contains to two ATP and no L-
methionine (TET) and represents ~24% of the population at intracellular concentrations 
of 150 µM L-met and 9.6 mM ATP (6).  Conversely, when MetNI is bound to two ATP 
and one L-methionine, TEMT and TMET, hydrolysis cannot occur (~74% of population). 
Intriguingly, we found that the presence of one bound L-methionine does not affect the 
binding affinity of either the first or second molecule of ATP.  For example, the binding 
affinity for 𝐸 + 𝑇   → 𝐸𝑇  is the same as that of 𝐸𝑀 + 𝑇   → 𝐸𝑀𝑇. Cooperative binding for 
ATP is maintained as well: 𝐸𝑇 + 𝑇   → 𝑇𝐸𝑇 is the same as that for 𝐸𝑀𝑇 + 𝑇   → 𝑇𝐸𝑀𝑇.  
These two observations suggest that the binding of one methionine may not induce a 
substantial enough conformational change at the NBD interface to affect nucleotide 
binding, and yet is able to disrupt catalysis.     
 
 
 
	   	  
S5
Derivation	  of	  basic	  equations	  for	  global	  modeling	  
	  
	  An	  ATPase	  reaction	  for	  a	  unireactant	  system	  can	  be	  visualized	  as:	  	  	  
	  	  	  	   	  The	  Michaelis-­‐Menten	  equation	  can	  be	  used	  to	  describe	  the	  ATPase	  reaction	  under	  rapid	  equilibrium	  conditions:	  	  	   𝑣 =   𝑘!"# ∗      𝐸 !   𝑆𝐾!   + 𝑆   =   𝑉!"# ∗ 𝑆𝐾!   + 𝑆   	  
	  	  where	  𝑣  is	   the	   initial	   velocity,	   	  [𝑆]	  is	   a	   fixed	   ATP	   concentration,	    [𝐸]!  is	   the	   total	  concentration	   of	   enzyme,	     𝑘!"# 	  is	   the	   catalytic	   rate	   constant,	   and	   𝐾! 	  is	   the	  dissociation	  constant	  for	  the	  ATP	  bound	  enzyme.	  	  	  	  This	  can	  be	  rewritten	  in	  an	  alternate	  form:	  	  	   𝑣𝐸 ! =   𝑘!"# =   𝑘!"#   ∗    [!]!!1+    [!]!!   	  	  	  where	  𝑘!"#	  is	  the	  observed	  rate	  constant.	  	  In	  this	  form,	  the	  numerator	  contains	  only	  one	  term,	  indicating	  that	  there	  exists	  only	  one	  product	  forming	  species.	   	  There	  are	  two	  terms	  in	  the	  denominator,	  indicating	  that	  there	  are	  a	  total	  of	  two	  species,	  free	  E	  and	  ES	  complex.	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Derivation	  of	  basic	  equations,	  continued	  
	  
	  In	   the	   presence	   of	   an	   inhibitor,	   the	   Michaelis-­‐Menten	   equation	   includes	   an	  additional	  term	  for	  the	  enzyme-­‐inhibitor	  complex:	  	  	  	  	   𝑣 =   𝑘!"#   ∗    [𝐸]!  [𝑆]𝐾!    1+    [!]!! + [𝑆]	  	  	  	  where	  [I]	  is	  a	  fixed	  concentration	  of	  inhibitor,	  and	  𝐾! 	  is	  the	  dissociation	  constant	  for	  the	  inhibitor	  bound	  enzyme.	  	  	  	  This	  can	  be	  rewritten	  in	  an	  alternate	  form:	  	  	   𝑘!"# =   𝑘!"#   ∗    [!]!!1+    [!]!! + [!]!! 	  	  	  	  	  	  	  	  
	   	  
S7
Modeling	  of	  ADP	  inhibition	  data:	  	  	   1. To	  obtain	  values	  for	  𝐾! ,𝑎,   𝑘!"#  in	  the	  global	  model,	  we	  first	  fit	  the	  data	  (𝑘!"#	  as	   a	   function	   of	   [ATP])	   in	   the	   absence	   of	   inhibitor	   (data	   points	   shown	   in	  Figure	   1c).	   Based	   on	   the	   Hill	   coefficient	   discussed	   in	   the	   main	   text,	   we	  assume	  that	  only	  the	  doubly	  ATP	  bound	  species	  can	  hydrolyze	  ATP	  (shown	  in	  the	  numerator).	  Thus	  the	  model	  presented	  here	  differs	  from	  that	  from	  the	  main	   text,	   since	  here	   it	  explicitly	  depends	  on	  T2,	  while	   the	  equations	   in	   the	  main	  text	  are	  dependent	  on	  TnH.	  There	  are	  a	  total	  of	  three	  possible	  species	  of	  enzyme,	   enzyme	   alone,	   singly	   bound	   by	   ATP,	   and	   doubly	   bound	   by	   ATP	  (represented	   in	   the	   denominator).	   If	   the	   identical	   ATP	   binding	   sites	   are	  cooperative,	   the	   binding	   of	   one	   molecule	   of	   ATP	   can	   alter	   the	   intrinsic	  dissociation	  constant	  of	  the	  vacant	  ATP	  site	  by	  the	  factor	  “a”.	  When	  the	  value	  of	  “a”	  is	  between	  0	  and	  1,	  the	  binding	  of	  ATP	  exhibits	  positive	  cooperativity.	  	  The	  equation	  is	  as	  follows:	  	  	   𝑘!"# =   𝑘!"#   ∗    !!!!!!1+    !!!! + !!!!!!   	  	  	   where	  	  	  	   𝑇	   —	   [ATP]	  	  𝐾!       	  	  —	   intrinsic	  dissociation	  constant	  for	  ATP	  	  𝑎	  	  	  	  	  	  	   —	   interaction	  factor	  for	  binding	  of	  second	  ATP	  	  𝑘!"#  	  	  —	   catalytic	  rate	  constant	  	  	  Parameter	  estimates	  are	  as	  follows:	  	   𝐾!       	  	  =	   560	  ±	  160	  μM	  	  𝑎	  	  	  	  	  	  	   =	   0.17	  ±	  0.08	  	  𝑘!"#  	  	  =	   17.5	  ±	  0.5	  min-­‐1	  	   	  	  	  
S8
	  
Modeling	  of	  ADP	  inhibition	  data,	  continued:	  
	  	   2. To	  obtain	  𝐾!	  and	  𝑐	  for	  the	  global	  fit,	  we	  then	  fit	  the	  data	  observed	  at	  subsaturating,	  constant	  [ATP]	  and	  varying	  [ADP].	  These	  data	  points	  are	  shown	  in	  Figure	  2A.	  	  	   𝑘!"# =      𝑉!"#!""1+    !!!! +    !!!!!!   	  	   where  	  	  𝑉!"#!""  —	   apparent	  maximal	  velocity	  at	  subsaturating	  ATP	  	  𝐷	  	   —	   	  [ADP]	  	  𝐾!	   —	   intrinsic	  dissociation	  constant	  for	  ADP	  	  𝑐	  	   —	   interaction	  factor	  for	  binding	  of	  second	  ADP	  	  	   Parameter	  estimates	  are	  as	  follows:	  	   𝐾!      	  	  =	   105	  ±	  5	  μM	  	  𝑐	  	  	  	  	  	  	   =	   0.68	  ±	  0.12	  	  𝑉!"#!""  	  	  =	   0.85	  ±	  0.01	  min-­‐1	  	  	  	  	  	   	  
S9
Modeling	  of	  ADP	  inhibition	  data,	  continued:	  	  	  3. From	  the	  parameter	  estimates	  obtained	  in	  Steps	  #1	  and	  #2,	  we	  fixed	  the	  values	  for	  the	  following	  parameters:	  	   	   𝐾! ,𝑎,𝐾!,  𝑐, 𝑘!"#        	  	  and	  globally	  fit	  the	  four	  data	  sets	  observed	  at	  constant	  [ADP]	  and	  varying	  [ATP]	  (data	  points	  shown	  in	  Figure	  2b)	  using	  the	  following	  equation:	  	  	  	   𝑘!"# =   𝑘!"#   ∗    !!!!!!1+    !!!! + !!!!!! + !!"!"!!! + !!!! +    !!!!!!    	  	  	   and	  fitting	  only	  one	  floating	  parameter:	   	  	   𝑏	   —	   interaction	  factor	  for	  binding	  of	  ATP	  with	  one	  bound	  ADP	  	   or	  binding	  of	  ADP	  with	  one	  bound	  ATP	  	   (these	  are	  thermodynamically	  equivalent)	  	  	  The	  parameter	  estimate	  is	  as	  follows:	  	   𝑏      	  	   =	   0.34	  ±	  0.03	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Modeling	  of	  L-­‐Methionine	  inhibition	  data	  	  	   4. To	  fix	  parameters	  𝐾! 	  and	  𝑑,	  we	  fit	  the	  data	  observed	  at	  saturating,	  constant	  [ATP]	  and	  varying	  [L-­‐met]	  	  (data	  points	  show	  in	  Figure	  3A).	  	   	   𝑘!"# =      𝑉!"#1+    !!!! +    !!!!!!  	  	  	   	  where	  	   𝐼	   —	   [L-­‐Methionine]	  	  	  𝐾! 	   —	   intrinsic	  dissociation	  constant	  for	  L-­‐Met	  	  𝑑	  	   —	   interaction	  factor	  for	  binding	  of	  second	  L-­‐Met	  	  𝑉!"#	  —	   maximal	  velocity	  	  	  Parameter	  estimates	  are	  as	  follows:	  	   𝐾!       	  	   =	   100	  ±	  4	  μM	  	  𝑑	  	  	  	  	  	  	   =	   0.91	  ±	  0.15	  	  𝑉!"#  	  	  =	   20.5	  ±	  0.16	  min-­‐1	  	  	  	  	  	  	   	  
S11
Modeling	  of	  L-­‐Methionine	  inhibition	  data,	  continued	  
	  
	   5. From	  the	  parameter	  estimates	  obtained	  in	  Steps	  #1	  and	  #4,	  we	  fixed	  the	  values	  for	  the	  following	  parameters:	  	  	   𝐾! ,𝑎,𝐾!,  𝑑, 𝑘!"#        	  	  	  and	  globally	  fit	  the	  four	  data	  sets	  observed	  at	  constant	  [L-­‐met]	  and	  varying	  [ATP]	  (data	  points	  shown	  in	  Figure	  3B)	  using	  the	  following	  equation:	  	  	  	  
𝑘!"# =   𝑘!"#   ∗    !!!!!!1 +    !!!! + !!!!!! + !!!! +    !!!!!! +    !!"!"!!! + !!!!!!!!!! + !!!!!!!!!! + !!!!ℎ!!!!!! 	  	   	  	  where	  	   𝑒	   —	   interaction	  factor	  for	  binding	  of	  one	  ATP	  with	  one	  bound	  L-­‐Met	  	   or	  binding	  of	  one	  L-­‐Met	  with	  one	  bound	  ATP	  	   	  𝑓	   —	   interaction	  factor	  for	  binding	  of	  second	  ATP	  with	  one	  bound	  	   	   L-­‐Met	  and	  one	  bound	  ATP	  	  	  𝑔	   —	   interaction	  factor	  for	  binding	  of	  second	  L-­‐Met	  with	  one	  bound	  	  	   ATP	  and	  one	  bound	  L-­‐Met	  	  	  
ℎ	   —	   interaction	  factor	  for	  binding	  of	  second	  ATP	  with	  two	  bound	  	  	   	   L-­‐Met	  and	  one	  bound	  ATP,	  or	  binding	  of	  second	  L-­‐Met	  with	  	  	   two	  bound	  ATP	  and	  one	  bound	  L-­‐Met	  	  	   6. We	  first	  chose	  to	  eliminate	  the	  doubly	  bound	  ATP,	  doubly	  bound	  L-­‐Met	  species	  as	  this	  is	  the	  least	  likely	  to	  be	  physiologically	  relevant.	  The	  equation	  was	  simplified	  to:	  	  	  
𝑘!"# =   𝑘!"#   ∗    !!!!!!1 +    !!!! + !!!!!! + !!!! +    !!!!!! +    !!"!"!!! + !!!!!!!!!! + !!!!!!!!!! 	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Modeling	  of	  L-­‐Methionine	  inhibition	  data,	  continued	  	  	   7. Next,	  as	  𝑓	  and	  𝑔	  depend	  on	  𝑒,	  we	  chose	  to	  focus	  on	  the	  𝑒	  parameter.	  	  We	  fixed	  𝑒	  at	  successive	  values	  and	  determined	  that	  the	  best	  fit	  was	  achieved	  when	  𝑒 = 1.	  	  The	  equation	  was	  further	  simplified	  to	  the	  following:	  	  	  
𝑘!"# =   𝑘!"#   ∗    !!!!!!1 +    !!!! + !!!!!! + !!!! +    !!!!!! +    !!"!!!! + !!!!!!!!!! + 2𝑇𝐼2𝑔𝐾𝑇𝐾𝐼2 	  	  
	   8. There	  were	  several	  combinations	  of	  values	  for	  𝑓	  and	  𝑔	  that	  resulted	  in	  same	  goodness-­‐of-­‐fit.	  	  	  	  	   9. We	  next	  tried	  to	  eliminate	  an	  additional	  species	  –	  either	  the	  doubly	  bound	  ATP,	  singly	  bound	  L-­‐met	  species	  or	  the	  doubly	  bound	  L-­‐met,	  singly	  bound	  ATP	  species.	  	  We	  were	  able	  to	  obtain	  a	  similar	  goodness-­‐of-­‐fit	  as	  Step	  #8	  only	  when	  the	  doubly	  bound	  L-­‐met,	  singly	  bound	  ATP	  species	  was	  eliminated.	  	  Thus	  the	  final	  equation	  for	  the	  global	  fitting	  is	  as	  follows:	  	  	   	  	  	  	  
𝑘!"# =   𝑘!"#   ∗    !!!!!!1 +    !!!! + !!!!!! + !!!! +    !!!!!! +    !!"!!!! + !!!!!!!!!! 	  	  	  	  	   and	  fitting	  only	  one	  floating	  parameter:	   	  	  	   𝑓	   —	   interaction	  factor	  for	  binding	  of	  second	  ATP	  when	  one	  ATP	  and	  	  	                                          one	  L-­‐Met	  are	  bound	  	  	  The	  parameter	  estimate	  is	  as	  follows:	  	   𝑓      	  	   =	   0.16	  ±	  0.01	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   10. The	  goodness-­‐of-­‐fit	  in	  the	  above	  steps	  was	  measured	  using	  the	  following	  equation:	  	  	  
%  𝑅𝑀𝑆𝐷 =    (!!!! !!"#!!!!"#!)!!!"#!!𝑛 	  	   	  	  where	  	   𝑛	   —	   number	  of	  average	  values	  from	  3	  independent	  experiments	  	  𝑘!"#	   —	   observed	  rate	  constant	  	  𝑘!"# 	  —	   modeled	  rate	  constant	  	  	  	  11. The	  %	  RMSD	  for	  the	  final	  fit	  (equation	  shown	  in	  Step	  #9)	  was	  2.3%.	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Table	  S1.	  	  Intrinsic	  dissociation	  constants	  Constant	   Description	   Value	  (μM)	  𝐾!!"#→!"#	   apo	  MetNI	  binds	  one	  ATP	   	  	  	  	  560	  ±	  170	  𝐾!!"#→!"#*	   ATP-­‐MetNI	  binds	  second	  ATP	   	  	  	  93	  ±	  55	  𝐾!!"#→!"#	   Apo	  MetNI	  binds	  one	  ADP	   	  	  	  110  ±	  10	  𝐾!!"#→!"#	   ADP-­‐MetNI	  binds	  second	  ADP	   	  	  	  72  ±	  12	  𝐾!!"#→!"#	   ATP-­‐MetNI	  binds	  one	  ADP	   	  35 ± 4	  𝐾!!"#→!"#	   ADP-­‐MetNI	  binds	  one	  ATP	   	  	  190 ±	  60	  𝐾!!"#→!"#	   Apo	  MetNI	  binds	  one	  Met	   100	  ±	  4	  𝐾!!"#→!"#	   Met-­‐MetNI	  binds	  second	  Met	   	  	  	  	  	  	  92	  ±	  15	  𝐾!!"#→!"#	   Met-­‐MetNI	  binds	  one	  ATP	   	  	  	  	  	  	  560 ±	  170	  𝐾!!"#→!"#	   ATP-­‐MetNI	  binds	  one	  Met	   	  	  100 ±    4	  𝐾!!"#/!"#→!"#	   ATP-­‐Met-­‐MetNI	  binds	  second	  ATP	   	  	  	  	  92 ±	  28	  *𝑘!"# =  18	  ±	  1	  𝑚𝑖𝑛!!  in	  the	  presence	  of	  two	  ATPs	  
 
  
	  The	  above	  intrinsic	  dissociation	  constants	  are	  defined	  in	  terms	  of	  binding	  to	  a	  single	  site	  (rather	  than	  a	  single	  molecule	  of	  MetNI).	  Numerical	  differences	  in	  constants	  between	  these	  values	  and	  those	  in	  the	  main	  text	  are	  due	  to	  differences	  in	  equations	  used	  for	  fitting,	  as	  described	  in	  Step	  #1.	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